Loading...
Loading...
India's melatonin imports from BULGARIA total $2.2K across 13 shipments from 3 foreign suppliers. BALKANPHARMA-DUPNITSA AD leads with $1.7K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for melatonin โ a concentrated sourcing relationship with select suppliers from BULGARIA.

BALKANPHARMA-DUPNITSA AD is the leading Melatonin supplier from BULGARIA to India, with import value of $1.7K across 11 shipments. The top 5 suppliers โ BALKANPHARMA-DUPNITSA AD, M S RX SOLUTION LIMITED, BALKANPHARMA DUPNITSA AD โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BALKANPHARMA-DUPNITSA AD | $1.7K | 11 | 75.2% |
| 2 | M S RX SOLUTION LIMITED | $341 | 1 | 15.3% |
| 3 | BALKANPHARMA DUPNITSA AD | $212 | 1 | 9.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $1.9K | 12 | 84.7% |
| 2 | BLUEFISH PHARMACEUTICALS PRIVATE LIMITED | $341 | 1 | 15.3% |
BULGARIA โ India trade corridor intelligence
The Bulgaria to India trade corridor for pharmaceutical imports, including melatonin formulations, is currently stable. Major ports such as Jawaharlal Nehru Port Trust (JNPT), Chennai, and Mundra are operating efficiently, with minimal congestion. Freight rates have remained consistent over the past year, and the exchange rate between the Indian Rupee (INR) and the Bulgarian Lev is favorable for importers. No significant disruptions have been reported in the supply chain, ensuring timely deliveries of melatonin formulations.
The Indian government's Production Linked Incentive (PLI) scheme aims to boost domestic manufacturing and reduce import dependency. However, melatonin formulations are not currently covered under this scheme, allowing continued imports from countries like Bulgaria. Import substitution policies are being considered, but melatonin formulations are not a primary focus, given the limited domestic production capacity. Therefore, imports from Bulgaria remain a viable option to meet market demand.
India and Bulgaria maintain a cordial trade relationship, with mutual recognition of Good Manufacturing Practices (GMP) standards facilitating smoother import processes. There are no active Free Trade Agreements (FTAs) between the two countries; however, bilateral discussions are ongoing to enhance trade relations. The pharmaceutical sector benefits from these engagements, with streamlined procedures for the import of melatonin formulations.
The estimated landed cost for importing melatonin formulations from Bulgaria to India is calculated as follows:
This estimate is per shipment and may vary based on actual values and any changes in duty rates or charges.
CDSCO registration, import licensing, and quality testing requirements
Importing finished pharmaceutical formulations containing melatonin into India requires compliance with the Drugs and Cosmetics Act, 1940, and associated rules. The Central Drugs Standard Control Organisation (CDSCO) mandates that all imported drugs be registered and approved. For melatonin formulations under HS Code 30049099, the importer must obtain a valid Drug Import License from the Directorate General of Foreign Trade (DGFT). Additionally, the manufacturer must provide a Certificate of Pharmaceutical Product (CoPP) and a Free Sale Certificate. The registration process typically takes 6 to 12 months, depending on the completeness of the submitted documentation. Importers should ensure that the melatonin formulations meet the standards set by the Indian Pharmacopoeia.
Upon arrival in India, each batch of imported melatonin formulations must undergo quality testing at a CDSCO-approved laboratory. The importer is required to submit a Certificate of Analysis (CoA) for each batch, demonstrating compliance with Indian Pharmacopoeia standards. Stability data, particularly for ICH Zone IV conditions, must be provided to ensure the product's efficacy and safety under Indian climatic conditions. Customs drug inspectors conduct port inspections to verify the authenticity of the documentation and the quality of the products. Any discrepancies or failures in quality testing can lead to delays, rejections, or destruction of the consignment.
Between 2024 and 2026, the CDSCO has implemented stricter regulations for the import of pharmaceutical formulations, including melatonin. The introduction of the Production Linked Incentive (PLI) scheme has incentivized domestic manufacturing, leading to a reduction in the import of certain formulations. However, melatonin formulations are not currently covered under the PLI scheme, maintaining their import viability. Bilateral agreements between India and Bulgaria have facilitated smoother trade relations, with mutual recognition of Good Manufacturing Practices (GMP) standards, thereby expediting the approval process for Bulgarian manufacturers.
Market demand, customs duty structure, and competitive landscape ยท Import duty: 17.10%
India imports finished melatonin formulations primarily due to the demand for patented and branded products not manufactured domestically. Specific dosage forms, such as extended-release tablets and liquid formulations, are often sourced from international markets to meet consumer preferences. Domestic capacity for melatonin production is limited, leading to a dependency on imports to fulfill market needs. The Indian market for melatonin formulations is valued at approximately $9.4 million, with 116 exporters supplying to 51 countries.
The Basic Customs Duty (BCD) for melatonin formulations under HS Code 30049099 is 10%. An additional Social Welfare Surcharge (SWS) of 10% is levied on the BCD, resulting in a total duty of 20%. The Integrated Goods and Services Tax (IGST) applicable is 12%, calculated on the sum of the CIF (Cost, Insurance, and Freight) value plus the total duty. There are no additional duties such as the National Calamity Contingent Duty (NCCD) or Health Cess for this product category. Importers should account for these duties when calculating the total landed cost of the product.
India sources melatonin formulations from Bulgaria due to the competitive advantages offered by Bulgarian manufacturers, including adherence to international quality standards and the ability to supply specialized dosage forms not readily available domestically. Bulgaria's share in India's melatonin import market is approximately 0.02%, with other major suppliers being China, Germany, and the United States. The preference for Bulgarian products is attributed to their consistent quality and compliance with regulatory requirements, which are crucial for the Indian market.
Import rationale, competitive comparison, supply chain risk, and procurement strategy
India imports melatonin formulations from Bulgaria due to the availability of specialized dosage forms and patented products not manufactured domestically. Bulgarian manufacturers offer high-quality melatonin tablets and capsules that meet international standards, fulfilling specific market needs in India. The ability to supply these specialized formulations makes Bulgaria a preferred sourcing destination for Indian importers.
When compared to other sources like China, Germany, and the United States, Bulgaria offers competitive pricing and consistent quality. While China may offer lower prices, concerns about quality and regulatory compliance can be a deterrent. Germany and the United States provide high-quality products but at higher costs. Bulgaria's unique advantage lies in its ability to balance quality and cost-effectiveness, making it an attractive option for Indian importers.
Potential risks for Indian importers include currency fluctuations, regulatory changes in Bulgaria, and shipping disruptions. To mitigate these risks, importers should establish strong relationships with Bulgarian suppliers, monitor currency exchange rates, and maintain adequate inventory levels. There have been no significant shortages reported in the supply of melatonin formulations from Bulgaria to India in recent years.
Import license checklist, document requirements, quality testing, and compliance
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Melatonin suppliers from BULGARIA to India include BALKANPHARMA-DUPNITSA AD, M S RX SOLUTION LIMITED, BALKANPHARMA DUPNITSA AD. The leading supplier is BALKANPHARMA-DUPNITSA AD with import value of $1.7K USD across 11 shipments. India imported Melatonin worth $2.2K USD from BULGARIA in total across 13 shipments.
India imported Melatonin worth $2.2K USD from BULGARIA across 13 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Melatonin sourced from BULGARIA include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, BLUEFISH PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $1.9K in imports across 12 shipments.
The total value of Melatonin imports from BULGARIA to India is $2.2K USD, across 13 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
3 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists